OPKO Health - OPK Net Assets per Single Share

Graphic logo of OPKO Health, Inc. (OPK)

OPKO Health, Inc. (OPK) manages a diversified holding company in the medical and pharmaceutical sectors. The price action reflects market expectations regarding management's strategy to integrate diagnostic and drug assets. The business relies on the BioReference network and developments for rare disease therapies, covering both B2B and B2C segments. Meanwhile, the indicator stands at 1.60, which is attributed to limited pricing power due to reduced insurance payouts, offset by patent royalties.

OPK: OPKO Health Inc Net Asset Value per Share 07/04/2022 - 10/27/2026

opko.com - analytical breakdowns and key metrics (OPK)

- price and consensus price forecast:
Price Chart OPKO Corp|OPK - Analyst Consensus Forecast
- market capitalization data:
Market Value OPKO Health, Inc.|OPK - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share OPKO Health|OPK - Total Stockholders' Equity|Market Capitalization to Book Value Ratio opko.com|OPK - Total Business Assets
- debt and liquidity data:
Total Debt to Capital OPKO Health, Inc.|OPK - Long-Term Debt to Capital|Short-Term Debt to Equity OPKO Health|OPK - Company Aggregate Debt|Debts to Book Capitalization OPKO Health, Inc.
Analysis of all company metrics:OPKO Corp (OPK)
Manufactured products of OPKO Health

The equity per share valuation allows for the determination of the intrinsic margin of safety for OPKO Health, Inc. (OPK). This metric measures the net asset value available to the shareholder after all liabilities have been settled. Analyzing the BVPS helps track the pace of capital accumulation and the risk of balance sheet bloating. Stable growth of this indicator is supported by a consistent cash flow from the diagnostic laboratory network. Predictable demand for tests guarantees the long-term capitalization of the business.

Competitor analysis for OPKO Health, Inc.

Agilent Tech - Net Assets per Single Share|DGX: Book Value per Share|ILMN (Illumina, Inc.) - Net Assets per Single Share|exactsciences.com (EXAS) - Accounting Value per Share|Book Value per Share RVTY (Revvity)|Net Asset Value per Share Bio-Rad Laboratories, Inc.|Book Value per Share Anbio Tech NNNN|Equity per Share Nordion (SHC)|Book Value per Share QDEL (QuidelOrtho)|CareDx Health - Book Value per Share|Maravai LifeSciences Holdings, Inc. (MRVI) - Net Assets per Single Share|FLGT - Equity per Share|LAB: Book Value per Share|CTKB (Cytek Corp) - Book Value per Share|Net Assets per Single Share OraSure Technologies|Net Assets per Single Share Exagen Diagnostics (XGN)|MDxHealth - Accounting Value per Share|Net Asset Value per Share LUCD (Lucid Diagnostics, Inc.)|Net Assets per Single Share PRE|Net Assets per Share Insight Molecular Diagnostics, Inc. IMDX|Book Value per Share TRIB (Trinity Biotech Corp)|PRPH: Net Assets per Share|Ainos - Net Assets per Single Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|Net Assets per Single Share HSCS (Heart Test Laboratories Inc.)|Net Asset Value per Share BMRA|CDIO - Net Assets per Single Share|Share Book Value VRAX (viraxbiolabs.com)|Net Assets per Single Share BJDX (Bluejay Diagnostics, Inc.)|Aspira Women's Health, Inc. - Book Value per Share|AXDX (Accelerate Diagnostics, Inc) - Net Assets per Single Share|Centogene N.V. (CNTG) - Net Asset Value per Share|Accounting Value per Share enzo.com ENZ|Fresh2 Group (FRES) - Accounting Value of a Share|GENE - Book Value per Share|Accounting Value of a Share 23andMe Holding Co|Psychemedics Corp - Book Value per Share